IO Biotech, Inc. (IOBTQ) Preferred Stock Liabilities (2020 - 2021)
IO Biotech's (IOBTQ) quarterly Preferred Stock Liabilities came in at $37.9 million in Q3 2021, little changed YoY from $37.9 million in Q3 2020, and little changed on a QoQ basis from $37.9 million in Q2 2021.
IO Biotech, Inc. (IOBTQ) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
IO Biotech (IOBTQ) has 2 years of Preferred Stock Liabilities data on file, last reported at $37.9 million in Q3 2021.
- Quarterly Preferred Stock Liabilities changed 0.0% year-over-year to $37.9 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $37.9 million (changed 0.0% YoY) and the FY2020 annual result came in at $37.9 million, changed N/A from the prior year.
- Preferred Stock Liabilities steadied at $37.9 million in Q3 2021, from $37.9 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $63.0 million in Q1 2021 to a low of $37.9 million in Q3 2020.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 37.91 Mn |
| Jun 30, 2021 | 37.91 Mn |
| Mar 31, 2021 | 62.98 Mn |
| Dec 31, 2020 | 37.91 Mn |
| Sep 30, 2020 | 37.91 Mn |